stockrow
Friday 6 November 2026
Export RTSN’s income statement to Excel — free account
Retension Pharmaceuticals, Inc.
RTSN Healthcare Biotechnology
10.58
1.02
−8.79%
Follow RTSN
Alert me
Retension Pharmaceuticals, Inc. (RTSN) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CBUS Cibus, Inc. compare | n/m |
| VANI Vivani Medical, Inc. compare | n/m |
| SEER Seer, Inc. compare | n/m |
| VTVT vTv Therapeutics Inc. compare | n/m |
| MIST Milestone Pharmaceuticals Inc. compare | n/m |
| PMVP PMV Pharmaceuticals, Inc. compare | n/m |
| VXRT VAXART, INC. compare | 2.8× |
| ICCC ImmuCell Corporation compare | 117× |
| RTSN Retension Pharmaceuticals, Inc. | — |
| Biotechnology industry median | 10.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)